Your browser doesn't support javascript.
loading
Author Correction: A synthetic nanobody targeting RBD protects hamsters from SARS-CoV-2 infection.
Li, Tingting; Cai, Hongmin; Yao, Hebang; Zhou, Bingjie; Zhang, Ning; van Vlissingen, Martje Fentener; Kuiken, Thijs; Han, Wenyu; GeurtsvanKessel, Corine H; Gong, Yuhuan; Zhao, Yapei; Shen, Quan; Qin, Wenming; Tian, Xiao-Xu; Peng, Chao; Lai, Yanling; Wang, Yanxing; Hutter, Cedric A J; Kuo, Shu-Ming; Bao, Juan; Liu, Caixuan; Wang, Yifan; Richard, Audrey S; Raoul, Hervé; Lan, Jiaming; Seeger, Markus A; Cong, Yao; Rockx, Barry; Wong, Gary; Bi, Yuhai; Lavillette, Dimitri; Li, Dianfan.
Affiliation
  • Li T; State Key Laboratory of Molecular Biology, CAS Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences (CAS), Shanghai, China.
  • Cai H; State Key Laboratory of Molecular Biology, CAS Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences (CAS), Shanghai, China.
  • Yao H; State Key Laboratory of Molecular Biology, CAS Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences (CAS), Shanghai, China.
  • Zhou B; University of CAS, Beijing, China.
  • Zhang N; CAS Key Laboratory of Molecular Virology & Immunology, Institut Pasteur of Shanghai CAS, Shanghai, China.
  • van Vlissingen MF; CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Center for Influenza Research and Early-warning (CASCIRE), CAS-TWAS Center of Excellence for Emerging Infectious Diseases (CEEID), CAS, Beijing, China.
  • Kuiken T; Erasmus Laboratory Animal Science Center, Erasmus University Medical Center, Rotterdam, Netherlands.
  • Han W; European Research Infrastructure on Highly Pathogenic Agents (ERINHA-AISBL), Paris, France.
  • GeurtsvanKessel CH; European Research Infrastructure on Highly Pathogenic Agents (ERINHA-AISBL), Paris, France.
  • Gong Y; Department of Viroscience, Erasmus University Medical Center, Rotterdam, Netherlands.
  • Zhao Y; State Key Laboratory of Molecular Biology, CAS Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences (CAS), Shanghai, China.
  • Shen Q; University of CAS, Beijing, China.
  • Qin W; European Research Infrastructure on Highly Pathogenic Agents (ERINHA-AISBL), Paris, France.
  • Tian XX; Department of Viroscience, Erasmus University Medical Center, Rotterdam, Netherlands.
  • Peng C; University of CAS, Beijing, China.
  • Lai Y; CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Center for Influenza Research and Early-warning (CASCIRE), CAS-TWAS Center of Excellence for Emerging Infectious Diseases (CEEID), CAS, Beijing, China.
  • Wang Y; University of CAS, Beijing, China.
  • Hutter CAJ; CAS Key Laboratory of Molecular Virology & Immunology, Institut Pasteur of Shanghai CAS, Shanghai, China.
  • Kuo SM; CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Center for Influenza Research and Early-warning (CASCIRE), CAS-TWAS Center of Excellence for Emerging Infectious Diseases (CEEID), CAS, Beijing, China.
  • Bao J; National Facility for Protein Science in Shanghai, Shanghai Advanced Research Institute (Zhangjiang Laboratory), CAS, Shanghai, China.
  • Liu C; National Facility for Protein Science in Shanghai, Shanghai Advanced Research Institute (Zhangjiang Laboratory), CAS, Shanghai, China.
  • Wang Y; National Facility for Protein Science in Shanghai, Shanghai Advanced Research Institute (Zhangjiang Laboratory), CAS, Shanghai, China.
  • Richard AS; State Key Laboratory of Molecular Biology, CAS Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences (CAS), Shanghai, China.
  • Raoul H; University of CAS, Beijing, China.
  • Lan J; State Key Laboratory of Molecular Biology, CAS Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences (CAS), Shanghai, China.
  • Seeger MA; Institute of Medical Microbiology, University of Zurich, Zurich, Switzerland.
  • Cong Y; CAS Key Laboratory of Molecular Virology & Immunology, Institut Pasteur of Shanghai CAS, Shanghai, China.
  • Rockx B; State Key Laboratory of Molecular Biology, CAS Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences (CAS), Shanghai, China.
  • Wong G; State Key Laboratory of Molecular Biology, CAS Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences (CAS), Shanghai, China.
  • Bi Y; University of CAS, Beijing, China.
  • Lavillette D; State Key Laboratory of Molecular Biology, CAS Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences (CAS), Shanghai, China.
  • Li D; University of CAS, Beijing, China.
Nat Commun ; 13(1): 4359, 2022 Jul 27.
Article in En | MEDLINE | ID: mdl-35896553
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Nat Commun Journal subject: BIOLOGIA / CIENCIA Year: 2022 Document type: Article Affiliation country: China
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Nat Commun Journal subject: BIOLOGIA / CIENCIA Year: 2022 Document type: Article Affiliation country: China